Linked Life Data

21462516

Source:http://linkedlifedata.com/resource/pubmed/id/21462516

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
284
pubmed:dateCreated
2011-4-4
pubmed:abstractText
Metabolic acidosis is a prevalent complication in moderate and late stages of chronic kidney disease (CKD). It is established that the correction of metabolic acidosis may improve metabolic bone disorders and protein degradation in the skeletal muscle, two characteristic complications of patients with advanced CKD. In the last 18 months, three randomized controlled trials have drawn the attention on a novel indication to correct metabolic acidosis in these patients, i.e., halting CKD progression. These data show that sodium bicarbonate, a cheap and easily manageable treatment, may delay the progression of CKD and the need of a renal replacement therapy such as dialysis or kidney transplantation.
pubmed:language
fre
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1660-9379
pubmed:author
pubmed:issnType
Print
pubmed:day
2
pubmed:volume
7
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
478-82
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
[Sodium bicarbonate to slow the progression of chronic kidney disease].
pubmed:affiliation
Service de néphrologie, Département de médecine interne, CHUV, Lausanne.
pubmed:publicationType
Journal Article, English Abstract